Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers

NCT02259829 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Telmisartan/Amlodipine
DRUG: Telmisartan
DRUG: Amlodipine

Sponsor

Boehringer Ingelheim